Centaur
YC W19Boston, US Β· Founded 2017 Β· 45 employees Β· 10 known investors
Centaur.ai uses performance-based AI and collective intelligence methods to improve medical decision-making in skin lesion assessment for cancer detection. The company combines expert human judgment with AI algorithms weighted by demonstrated accuracy rather than credentials.
Also known as Centaur Labs Β· Centaur.ai
Founders & leadershipΒ· Y Combinator alumni (W19)
Centaur was founded in 2017 by Erik Duhaime, Tom Gellatly, and Zach Rausnitz.
Investors Β· 10
Also in the syndicate Β· 2
Company profile
researched Aug 2026Centaur.ai (formerly Centaur Labs) is a Boston-based data annotation company that produces labeled datasets for AI development in healthcare and other high-stakes domains. Its platform organizes annotation as a competition: subject matter experts and AI models label the same items independently, are continually measured and rewarded on measured performance, and their outputs are then aggregated with weights based on demonstrated accuracy rather than credentials or years of experience. The company states this aggregation yields results more accurate than either the best individual human annotator or the best individual AI model.
The workflow described by the company spans dataset design (using either a customer's raw data or data Centaur supplies), competitive annotation drawing on a stated network of more than 100,000 subject matter experts and/or AI models, aggregation of the strongest signals, and delivery of production-ready data via API, JSON, CSV, or DICOM for model training and evaluation. Annotation covers text, image, audio, video, and waveform data, with published examples including skin lesion classification, retinal OCT grading, ICD-10 code mapping, lung nodule segmentation, colonoscopy video annotation, and chest X-ray datasets. Experts compete on the company's mobile app, DiagnosUs, and work is delivered on a HIPAA-compliant platform.
Alongside labeling, Centaur publishes model evaluation and benchmark work, including health evaluations of frontier large language models, a calorie-estimation benchmark comparing humans with eight frontier AI models, and the MedAESQA medical question-answering benchmark.
Founding story
Centaur grew out of research at the MIT Center for Collective Intelligence. While founder Erik Duhaime was conducting PhD research on collective intelligence, he was inspired by his wife's medical training and began running experiments on combining the opinions of multiple medical professionals and AI algorithms to assess skin lesions for cancer. He found that weighting opinions by performance-based metrics rather than experience or credentials, and identifying how different human and machine opinions complement each other, produced more accurate results than the best individual doctor or the best AI algorithm alone. That research became the basis for the company, originally called Centaur Labs.
Business model
B2B services and platform: Centaur.ai sells annotated datasets and model evaluation work to organizations building AI, delivering production-ready data through APIs and standard file and imaging formats. Work is sourced from a distributed network of subject matter experts who compete on the company's DiagnosUs app and are rewarded according to measured annotation performance.
Traction
The company reports a network of over 100,000 subject matter experts on its site, while 2024 press coverage of its Series B cited over 50,000 experts. Published customer results include Paige improving an F1 score from 0.6 to 0.83, Eight Sleep moving from 70% to 93% accuracy with gamified labeling, SciBite reducing a project timeline by two months and surfacing roughly 5,000 candidate vocabulary synonyms, and a customer describing label volumes 10x to 20x what it had achieved internally. Other work includes a VUNO brain MRI FDA clearance case study and contributions to Microsoft's PadChest-GR dataset.
Latest developments
In November 2024 the company announced a $750,000 grant supporting research with Brigham and Women's Hospital. Recent work includes contributing to Microsoft's PadChest-GR chest X-ray dataset (January 2025), a partnership with Autoblocks (April 2025), the MedAESQA medical question-answering benchmark (August 2025), a HealthAwards.com Gold award for mobile digital health resources (December 2025), a calorie-estimation benchmark in which humans outperformed eight frontier AI models (July 2026), and a Grok 4.5 health evaluation (August 2026). The site also promotes a Centaur Arena in which experts and AI models compete on labeling tasks.
βΈFull profile β market position, technology, go-to-market, geography, history, risks & controversies
Market position
Centaur.ai positions itself in the expert data annotation and model evaluation market with a focus on healthcare and other domains where label accuracy is critical, differentiating from in-house annotation teams and outsourced generalist labeling providers. It was named to the CB Insights Digital Health 150 and won a HealthAwards.com Gold award for mobile digital health resources.
The company's stated differentiator is performance-based trust: annotators, whether people or models, are weighted by demonstrated accuracy rather than credentials or experience, and complementary opinions are combined so the aggregate outperforms the best single human or single algorithm. This 'centaur' approach, named after centaur chess in which humans collaborate with AI, originated in research at the MIT Center for Collective Intelligence.
Technology
The platform combines a distributed annotation workforce with quality measurement: annotators, human or AI, label items independently and are scored continuously, and an aggregation layer weights and combines opinions according to measured performance to produce a consensus label. Supported modalities include text, image, audio, video, and waveform, with DICOM and OHIF support for medical imaging and SAM-based auto-segmentation. Outputs are delivered via API, JSON, CSV, or DICOM. The company holds SOC 2 Type II certification.
Go-to-market
The company markets directly to AI and machine learning teams through demo requests, case studies, whitepapers, and an interactive labeling-quality tool on its site, and maintains a presence at industry and research conferences including HIMSS 2026, HumanX 2026, NeurIPS, RSNA 2022 and RSNA 2025, and MICCAI 2024. It also works through partnerships with data and tooling companies such as Protege, Autoblocks, Dandelion Health, Consensus, and Lucem Health.
Teams building AI in high-stakes domains, including medical device makers (software as a medical device and AI-enabled hardware), life sciences and drug discovery organizations, consumer health and cosmetics applications, insurance claims and customer service operations, and developers of LLMs and software requiring expert review. Named customers and case study subjects include Paige, Volastra Therapeutics, Eight Sleep, SciBite, VUNO, AIBerry, Consensus, Ryver, and Microsoft (PadChest-GR).
Geography
Headquartered in Boston, Massachusetts, with a distributed network of subject matter experts and a hybrid team; co-founder Tom Gellatly is based in Durham, North Carolina.
History
Co-founded in 2017 by Erik Duhaime, Tom Gellatly, and Zach Rausnitz, the company went through Y Combinator's Winter 2019 batch. It raised a $15 million Series A announced in September 2021 and a $16 million-plus Series B announced in October 2024, led by SignalFire. Partnerships and research collaborations followed with Brigham and Women's Hospital (2021), Lucem Health and the Mayo Clinic (2022), Consensus (2022), Dandelion Health (2022), Protege (2024), and Autoblocks (2025). The company subsequently rebranded from Centaur Labs to Centaur.ai.
Risks & controversies
Company materials note that as AI becomes ubiquitous a large 'tasker underclass' is emerging in the annotation labor market. Leaderboard figures shown on the company's home page carry a disclaimer that AI model scores are representative and may not reflect actual results, and that specialist names are anonymized.
Compiled by commissioned research from 8 cited public sources β announcements, filings, and press listed under research sources below.
Key figures
latest reportedCompany-reported or press-reported figures, each dated to when it was claimed β not independently audited.
Competitors Β· 3
by search overlapCompanies competing with Centaur for the same Google search keywords, organic and paid, via search-intersection analysis.
Timeline Β· 17
launches, deals, and filingsBenchmark reporting that humans outperformed eight frontier AI models at calorie estimation.
$750K source β
Boston-based health data annotation company Centaur Labs raised $16M+ in Series B funding led by SignalFire, with participation from Matrix, Accel, Susa, Omega, Y Combinator and new investors Samsung Next and Alumni Ventures, to expand operations and development efforts.
$16M source β
Centaur Labs launched an on-demand AI data labeling product enabling AI developers to collect labels from experts in under one hour.
The company announced a Series A round; press coverage reported $15 million to improve data for healthcare AI.
$15M source β
Dated company events from announcements, filings, and press; legal rows summarize public dockets and regulator releases.
In the news
βΈResearch sources Β· 8
primary sources listed
- Centaurcentaur.ai Β· web
8 public sources were cited for this profile; the first-party ones are listed here.
Frequently asked questions
- What does Centaur do?
- Centaur.ai runs competitive, performance-scored annotation by human experts and AI models to produce training and evaluation data for healthcare AI.
- Who founded Centaur?
- Centaur was founded by Erik Duhaime, Tom Gellatly, Zach Rausnitz in 2017.
- Who are Centaur's investors?
- Centaur's investors include SBXi, Y Combinator, Accel, Alumni Ventures, Matrix, Samsung Next, SignalFire, Susa Ventures.
- Where is Centaur headquartered?
- Centaur is headquartered in Boston, US.





